% alzhub.org library filter % Source: https://alzhub.org/research?category=down_syndrome&year=2022 % 12 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{videla2022-35930282, author = {Videla, L. and Benejam, B. and Pegueroles, J. and Carmona-Iragui, M. and Padilla, C. and Fernández, S. and Barroeta, I. and Altuna, M. and others}, title = {{Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome}}, journal = {JAMA network open}, year = {2022}, doi = {10.1001/jamanetworkopen.2022.25573}, pmid = {35930282}, url = {https://doi.org/10.1001/jamanetworkopen.2022.25573} } @article{oeckl2022-35340050, author = {Oeckl, P. and Wagemann, O. and Halbgebauer, S. and Anderl-Straub, S. and Nuebling, G. and Prix, C. and Loosli, S. V. and Wlasich, E. and others}, title = {{Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181}}, journal = {Annals of neurology}, year = {2022}, doi = {10.1002/ana.26360}, pmid = {35340050}, url = {https://doi.org/10.1002/ana.26360} } @article{drummond2022-35418158, author = {Drummond, E. and Kavanagh, T. and Pires, G. and Marta-Ariza, M. and Kanshin, E. and Nayak, S. and Faustin, A. and Berdah, V. and others}, title = {{The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome}}, journal = {Acta neuropathologica communications}, year = {2022}, doi = {10.1186/s40478-022-01356-1}, pmid = {35418158}, url = {https://doi.org/10.1186/s40478-022-01356-1} } @article{neri2022-35596580, author = {Neri, S. and Mastroianni, G. and Gardella, E. and Aguglia, U. and Rubboli, G.}, title = {{Epilepsy in neurodegenerative diseases}}, journal = {Epileptic disorders : international epilepsy journal with videotape}, year = {2022}, doi = {10.1684/epd.2021.1406}, pmid = {35596580}, url = {https://doi.org/10.1684/epd.2021.1406} } @article{lott2022-36419175, author = {Lott, I. T. and Kirby, K. A. and Doran, E. and Grill, J. D.}, title = {{Research attitudes in families of individuals with Down syndrome: importance for clinical trials}}, journal = {Alzheimer's research \& therapy}, year = {2022}, doi = {10.1186/s13195-022-01120-6}, pmid = {36419175}, url = {https://doi.org/10.1186/s13195-022-01120-6} } @article{martini2022-35472307, author = {Martini, A. C. and Gross, T. J. and Head, E. and Mapstone, M.}, title = {{Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome}}, journal = {Neuron}, year = {2022}, doi = {10.1016/j.neuron.2022.04.001}, pmid = {35472307}, url = {https://doi.org/10.1016/j.neuron.2022.04.001} } @article{jin2022-35803230, author = {Jin, M. and Xu, R. and Wang, L. and Alam, M. M. and Ma, Z. and Zhu, S. and Martini, A. C. and Jadali, A. and others}, title = {{Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's disease}}, journal = {Cell stem cell}, year = {2022}, doi = {10.1016/j.stem.2022.06.007}, pmid = {35803230}, url = {https://doi.org/10.1016/j.stem.2022.06.007} } @article{nubling2022-35320851, author = {Nübling, G. and Wagemann, O. and Loosli, S. V. and Wlasich, E. and Danek, A. and Levin, J.}, title = {{[Diagnosing Alzheimer Dementia in People with Down Syndrome in Accordance with ICD, DSM V and A/T/N System]}}, journal = {Fortschritte der Neurologie-Psychiatrie}, year = {2022}, doi = {10.1055/a-1771-6273}, pmid = {35320851}, url = {https://doi.org/10.1055/a-1771-6273} } @article{skotko2023-36437642, author = {Skotko, B. G. and Krell, K. and Haugen, K. and Torres, A. and Nieves, A. and Dhand, A.}, title = {{Personal social networks of people with Down syndrome}}, journal = {American journal of medical genetics. Part A}, year = {2023}, doi = {10.1002/ajmg.a.63059}, pmid = {36437642}, url = {https://doi.org/10.1002/ajmg.a.63059} } @article{im2022-4ba4a0f3, author = {Im, E. and Jiang, Y. and Stavrides, P. and Darji, S. and Erdjument-Bromage, H. and Neubert, T. A. and Choi, J. Y. and Wegiel, J. and others}, title = {{Lysosomal dysfunction in Down Syndrome and Alzheimer mouse models is caused by selective v-ATPase inhibition by Tyr 682 phosphorylated APP βCTF}}, journal = {Science advances}, year = {2022}, doi = {10.1101/2022.06.02.494546}, url = {https://doi.org/10.1101/2022.06.02.494546} } @article{ganguly2023-36371073, author = {Ganguly, B. B. and Kadam, N. N.}, title = {{Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome}}, journal = {Mitochondrion}, year = {2023}, doi = {10.1016/j.mito.2022.11.003}, pmid = {36371073}, url = {https://doi.org/10.1016/j.mito.2022.11.003} } @article{czerminski2022-be7d48c0, author = {Czerminski, J. T. and King, O. D. and Lawrence, J. B.}, title = {{Modeling Down syndrome neurodevelopment with isogenic cerebral organoids}}, journal = {bioRxiv}, year = {2022}, doi = {10.1101/2022.05.25.493459}, url = {https://doi.org/10.1101/2022.05.25.493459} }